{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:04:08Z","timestamp":1791489848331,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP 20ek0410069h0001"],"award-info":[{"award-number":["JP 20ek0410069h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology, Japan","award":["21-19"],"award-info":[{"award-number":["21-19"]}]},{"name":"Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology, Japan","award":["21-19"],"award-info":[{"award-number":["21-19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with rheumatoid arthritis (RA) are at a higher risk for sarcopenia than the general population. Exercise therapy can improve muscle strength in older adults; however, its efficacy in older patients with RA has not been fully established. This study aimed to evaluate the efficacy of a personalized exercise program on physical function in older patients with RA at high risk for sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-centre, parallel-group, two-arm, superiority randomized controlled trial was conducted in patients with RA aged 60\u201385 years who were at risk of sarcopenia. The intervention group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200969) underwent a 16-week personalized exercise program in addition to nutritional guidance and standard care, whereas the control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200965) received only nutritional guidance and standard care. The primary outcome was the change in the total Short Physical Performance Battery (SPPB) scores from baseline to week 16.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 140 patients were randomized. Of these, 134 initiated the assigned intervention. There was a 0.2-point difference in SPPB total score from baseline to week 16 between the intervention group (+\u20090.4 points) and the control group (+\u20090.2 points); 95% confidence interval: -0.1 to 0.5;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.206. Regarding the secondary outcomes at week 16, there was a tendency for improvement in the chair-stand test, grip strength, and the mental component score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 16-week personalized exercise therapy did not improve the total SPPB scores. However, the intervention may improve standing ability, grip strength, and mental health-related quality of life in older patients with RA at high risk of sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was registered with UMINCTR (trial number: UMIN000044930).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-026-03751-8","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:47:48Z","timestamp":1770378468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of a personalized exercise program on physical function in older patients with rheumatoid arthritis at high risk of sarcopenia: results of a randomized controlled trial"],"prefix":"10.1186","volume":"28","author":[{"given":"Mie","family":"Torii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Onizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Urai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirei","family":"Shirakashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Hiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayae","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"3751_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412\u201323.","journal-title":"Age Ageing"},{"key":"3751_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.maturitas.2020.01.004","volume":"133","author":"F Petermann-Rocha","year":"2020","unstructured":"Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. Factors associated with sarcopenia: a cross-sectional analysis using UK biobank. Maturitas. 2020;133:60\u20137.","journal-title":"Maturitas"},{"key":"3751_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14397595.2018.1510565","volume":"29","author":"M Torii","year":"2019","unstructured":"Torii M, Hashimoto M, Hanai A, Fujii T, Furu M, Ito H, et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod Rheumatol. 2019;29:589\u201395.","journal-title":"Mod Rheumatol"},{"key":"3751_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40200-017-0302-x","volume":"16","author":"G Shafiee","year":"2017","unstructured":"Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.","journal-title":"J Diabetes Metab Disord"},{"key":"3751_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jcsm.13225","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Shi Q, Nong K, Li S, Yue J, Huang J, et al. Exercise for sarcopenia in older people: a systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:1199\u2013211.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3751_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.clnu.2017.08.016","volume":"37","author":"SM Robinson","year":"2018","unstructured":"Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37:1121\u201332.","journal-title":"Clin Nutr"},{"key":"3751_CR7","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s40279-015-0385-9","volume":"45","author":"R Borde","year":"2015","unstructured":"Borde R, Hortob\u00e1gyi T, Granacher U. Dose\u2013Response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med. 2015;45:1693\u2013720.","journal-title":"Sports Med"},{"key":"3751_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/rheumatology\/ker330","volume":"51","author":"A Baillet","year":"2012","unstructured":"Baillet A, Vaillant M, Guinot M, Juvin R, Gaudin P. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology. 2012;51:519\u201327.","journal-title":"Rheumatology"},{"key":"3751_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/art.21165","volume":"53","author":"M Munneke","year":"2005","unstructured":"Munneke M, de Jong Z, Zwinderman AH, Ronday HK, van Schaardenburg D, Dijkmans BAC, et al. Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthritis Rheum. 2005;53:410\u20137.","journal-title":"Arthritis Rheum"},{"key":"3751_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12891-023-06185-4","volume":"24","author":"A Onishi","year":"2023","unstructured":"Onishi A, Torii M, Hidaka Y, Uozumi R, Oshima Y, Tanaka H, et al. Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial. BMC Musculoskelet Disord. 2023;24:280.","journal-title":"BMC Musculoskelet Disord"},{"key":"3751_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"3751_CR12","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2022.21243","volume":"328","author":"NJ Butcher","year":"2022","unstructured":"Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial protocols: the SPIRIT-outcomes 2022 extension. JAMA. 2022;328:2345\u201356.","journal-title":"JAMA"},{"key":"3751_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","volume":"167","author":"I Boutron","year":"2017","unstructured":"Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, et al. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167:40\u20137.","journal-title":"Ann Intern Med"},{"key":"3751_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726\u201332.","journal-title":"Ann Intern Med"},{"key":"3751_CR15","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"3751_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Arai H, Assantachai P, Akishita M, Chew STH, Dumlao LC, et al. Asian working group for Sarcopenia. 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300\u20137.","journal-title":"J Am Med Dir Assoc"},{"key":"3751_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"3751_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12979-020-00184-y","volume":"17","author":"SEM Andersson","year":"2020","unstructured":"Andersson SEM, Lange E, Kucharski D, Svedlund S, Onnheim K, Bergquist M, et al. Moderate- to high-intensity aerobic and resistance exercise reduces peripheral blood regulatory cell populations in older adults with rheumatoid arthritis. Immun Ageing. 2020;17:12.","journal-title":"Immun Ageing"},{"key":"3751_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0140-6736(14)60998-3","volume":"385","author":"SE Lamb","year":"2015","unstructured":"Lamb SE, Williamson EM, Heine PJ, Adams J, Dosanjh S, Dritsaki M, et al. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet. 2015;385:421\u20139.","journal-title":"Lancet"},{"key":"3751_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1177\/0269215517698732","volume":"31","author":"FM Lourenzi","year":"2017","unstructured":"Lourenzi FM, Jones A, Pereira DF, Santos J, Furtado RNV, Natour J. Effectiveness of an overall progressive resistance strength program for improving the functional capacity of patients with rheumatoid arthritis: a randomized controlled trial. Clin Rehabil. 2017;31:1482\u201391.","journal-title":"Clin Rehabil"},{"key":"3751_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:85\u201394.","journal-title":"J Gerontol"},{"key":"3751_CR22","doi-asserted-by":"publisher","first-page":"10612","DOI":"10.3390\/ijerph182010612","volume":"18","author":"C de F\u00e1tima Ribeiro Silva","year":"2021","unstructured":"de F\u00e1tima Ribeiro Silva C, Ohara DG, Matos AP, Pinto ACPN, Pegorari MS. Short physical performance battery as a measure of physical performance and mortality predictor in older adults: a comprehensive literature review. Int J Environ Res Public Health. 2021;18:10612.","journal-title":"Int J Environ Res Public Health"},{"key":"3751_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"3751_CR24","first-page":"1","volume":"49","author":"N Murase","year":"2002","unstructured":"Murase N, Katsumura T, Ueda C, Inoue S. Validity and reliability of the Japanese version of the international physical activity questionnaire. J Health Welf Stat. 2002;49:1\u20139.","journal-title":"J Health Welf Stat"},{"key":"3751_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007;66:407\u20139.","journal-title":"Ann Rheum Dis"},{"key":"3751_CR26","doi-asserted-by":"crossref","unstructured":"Aletaha D, Nell VPK, Stamm T, Uffmann M, Pflugbeil S, Machold K et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4): R796\u2013806.","DOI":"10.1186\/ar1740"},{"key":"3751_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology. 2003;42:244\u201357.","journal-title":"Rheumatology"},{"key":"3751_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137\u201345.","journal-title":"Arthritis Rheum"},{"key":"3751_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341\u201353.","journal-title":"Health Econ"},{"key":"3751_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","volume":"51","author":"S Fukuhara","year":"1998","unstructured":"Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51:1037\u201344.","journal-title":"J Clin Epidemiol"},{"key":"3751_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220\u201333.","journal-title":"Med Care"},{"key":"3751_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"3751_CR33","first-page":"309","volume":"38","author":"H Hatta","year":"1998","unstructured":"Hatta H, Higashi A, Yashiro H, Ozasa K, Hayashi K, Kiyota K, et al. A validation of the hospital anxiety and depression scale. Jpn J Psychosom Med. 1998;38:309\u201315.","journal-title":"Jpn J Psychosom Med"},{"key":"3751_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2026141","volume":"385","author":"DW Kitzman","year":"2021","unstructured":"Kitzman DW, Whellan DJ, Duncan P, Pastva AM, Mentz RJ, Reeves GR, et al. Physical rehabilitation for older patients hospitalized for heart failure. N Engl J Med. 2021;385:203\u201316.","journal-title":"N Engl J Med"},{"key":"3751_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jama.2014.469","volume":"311","author":"NK Latham","year":"2014","unstructured":"Latham NK, Harris BA, Bean JF, Heeren T, Goodyear C, Zawacki S, et al. Effect of a home-based exercise program on functional recovery following rehabilitation after hip fracture: a randomized clinical trial. JAMA. 2014;311:700\u20138.","journal-title":"JAMA"},{"key":"3751_CR36","doi-asserted-by":"publisher","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","volume":"3","author":"D Rooks","year":"2020","unstructured":"Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020;3:e2020836.","journal-title":"JAMA Netw Open"},{"key":"3751_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol Biol Sci Med Sci. 2002;57:326\u201332.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3751_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3389\/fphys.2017.01045","volume":"8","author":"S Dalle","year":"2017","unstructured":"Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045.","journal-title":"Front Physiol"},{"key":"3751_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.aller.2013.11.003","volume":"43","author":"AK Shrivastava","year":"2015","unstructured":"Shrivastava AK, Singh HV, Raizada A, Singh SK, Pandey A, Singh N, et al. Inflammatory markers in patients with rheumatoid arthritis. Allergol Immunopathol. 2015;43:81\u20137.","journal-title":"Allergol Immunopathol"},{"key":"3751_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/RHU.0b013e318190f95f","volume":"15","author":"HG Flint-Wagner","year":"2009","unstructured":"Flint-Wagner HG, Lisse J, Lohman TG, Going SB, Guido T, Cussler E, et al. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients. J Clin Rheumatol. 2009;15:165\u201371.","journal-title":"J Clin Rheumatol"},{"key":"3751_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/PHM.0000000000000564","volume":"96","author":"US Siqueira","year":"2017","unstructured":"Siqueira US, Orsini Valente LG, de Mello MT, Szejnfeld VL, Pinheiro MM. Effectiveness of aquatic exercises in women with rheumatoid arthritis: a randomized, controlled, 16-week intervention\u2014the hydra trial. Am J Phys Med Rehabil. 2017;96:167\u201375.","journal-title":"Am J Phys Med Rehabil"},{"issue":"12","key":"3751_CR42","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/art.24891","volume":"61","author":"AB Lemmey","year":"2009","unstructured":"Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum. 2009;61(12):1726\u201334. https:\/\/doi.org\/10.1002\/art.24891.","journal-title":"Arthritis Rheum"},{"key":"3751_CR43","doi-asserted-by":"publisher","first-page":"111834","DOI":"10.1016\/j.exger.2022.111834","volume":"164","author":"VKDS Lage","year":"2022","unstructured":"Lage VKDS, de Paula FA, Lima LP, Santos JNV, Dos Santos JM, Viegas \u00c2A, et al. Plasma levels of myokines and inflammatory markers are related with functional and respiratory performance in older adults with COPD and sarcopenia. Exp Gerontol. 2022;164:111834.","journal-title":"Exp Gerontol"},{"key":"3751_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.archger.2013.06.003","volume":"57","author":"D Legrand","year":"2013","unstructured":"Legrand D, Adriaensen W, Vaes B, Mathe\u00ef C, Wallemacq P, Degryse J. The relationship between grip strength and muscle mass, inflammatory biomarkers and physical performance in community-dwelling very old persons. Arch Gerontol Geriatr. 2013;57:345\u201351.","journal-title":"Arch Gerontol Geriatr"},{"key":"3751_CR45","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.ctcp.2023.101795","volume":"53","author":"AM Ahmad","year":"2023","unstructured":"Ahmad AM, Serry ZH, Abd Elghaffar HA, Ghazi HA, El Gayar SL. Effects of aerobic, resistance, and combined training on thyroid function and quality of life in hypothyroidism. A randomized controlled trial. Complement Ther Clin Pract. 2023;53:101795.","journal-title":"Complement Ther Clin Pract"},{"key":"3751_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.archger.2019.05.003","volume":"83","author":"IM Cardalda","year":"2019","unstructured":"Cardalda IM, L\u00f3pez A, Carral JMC. The effects of different types of physical exercise on physical and cognitive function in frail institutionalized older adults with mild to moderate cognitive impairment. A randomized controlled trial. Arch Gerontol Geriatr. 2019;83:223\u201330.","journal-title":"Arch Gerontol Geriatr"},{"key":"3751_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1186\/s12877-024-05464-6","volume":"24","author":"J Fang","year":"2024","unstructured":"Fang J, Ren J, Wang J, Qiu X, Zhang S, Yuan S, et al. Combining motivational and exercise intervention components to reverse pre-frailty and promote self-efficacy among community-dwelling pre-frail older adults: a randomized controlled trial. BMC Geriatric. 2024;24:896.","journal-title":"BMC Geriatric"},{"key":"3751_CR48","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2337\/dc12-1153","volume":"36","author":"VH Myers","year":"2013","unstructured":"Myers VH, McVay MA, Brashear MM, Johannsen NM, Swift DL, Kramer K, et al. Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2013;36:1884\u201390.","journal-title":"Diabetes Care"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03751-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:05:30Z","timestamp":1773151530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03751-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3751"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03751-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Kyoto University Ethics Committee (approval number: C1545-1) and registered with UMINCTR (trial number: UMIN000044930)10. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Department of Advanced Medicine for Rheumatic Diseases is supported by Nagahama City, Shiga, Japan; Toyooka City, Hyogo, Japan; and two pharmaceutical companies (AYUMI Pharmaceutical Co., and Asahi Kasei Pharma Corp.). The above-mentioned pharmaceutical companies were not involved in the study design, manuscript writing, or manuscript submission and will not be involved in data collection and analysis.AO received research grants and\/or speaker fees from Pfizer Inc., Bristol-Myers Squibb., Advantest, Taisho pharmaceutical Holdings Co. Ltd, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K. K., Ono Pharmaceutical Co., UCB Japan Co. Ltd, Mitsubishi Tanabe Pharma Co. Ltd, Eisai Co. Ltd., Abbvie Inc., and Daiichi Sankyo Co. Ltd. RU has received personal fees from Eisai, Sawai Pharmaceutical, SBI Pharmaceuticals, Daiichi Sankyo, Statcom, and EPS Corporation, and lecture fees from Janssen Pharmaceuticals, Nippon Kayaku, and SAS Institute Japan outside this work. HO has received speaker fee from Abbvie Inc., Chugai Pharmaceutical Co. Ltd, Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co. Ltd., Daiichi Sankyo Co. Ltd, and Taisho pharmaceutical Holdings Co. Ltd.TF has received research grants and\/or speaker fees from Kakenhi 24K11614, Abbvie Inc., Abbvie Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd. Daiichi Sankyo Co. Ltd, Eisai Co. Ltd, Gilead Sciences, Inc., Janssen Pharmaceutical K.K, and Mitsubishi Tanabe Pharma Co.Ltd. KM has received consulting and\/or speaker fee from Asahi Kasei Pharma Corp, Abbvie Inc., Eisai Co. Ltd, Pfizer Inc., Eli Lilly Japan K. K., Astellas Pharma Inc, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd, and Mitsubishi Tanabe Pharma Co.Ltd, MT received research grants and\/or speaker fees from Abbvie GK., Astellas Pharma Inc., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Nippon Zoki Pharmaceutical Co. Ltd., Pfizer Inc., Taisho pharmaceutical Holdings Co. Ltd, Teijin Pharma, Ltd. and UCB Japan Co. Ltd. RH received research grants and\/or speaker fee from Eli Lilly Japan K.K, Abbvie GK., GSK plc., Asahi Kasei Pharma Corp, Kissei, Bristol-Myers Squibb Company, Pfizer Inc., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co. Eisai Co. Ltd., and UCB Japan Co., Ltd. SM received speaker fee from Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co., Asahi Kasei Pharma Corp, Taisho pharmaceutical Holdings Co., Chugai Pharmaceutical Co. Ltd., AYUMI Pharmaceutical Co., Eisai Co, and Pfizer Inc., AM received research grants and\/or speaker fee from Asahi Kasei Pharma Corp, Astellas Pharma Inc, Abbvie GK., Asahi Kasei Pharma Corp, Chugai Pharmaceutical Co. Ltd. Mitsubishi Tanabe Pharma Co., Eli Lilly, Bristol-Myers Squibb Company, Pfizer Inc., Eisai Co. Ltd., HA received research grants and\/or speaker fee from Tsumura & Co. MH received research grants and\/or speaker fee from Abbvie, Asahi Kasei, Astellas, Brystol Meyers, Chugai, EA Pharma, Eisai, Daiichi Sankyo, Eli Lilly, Novartis Pharma, Taisho Toyama, Tanabe Mitsubishi, UCB Japan. M Torii, YH, K Murakami, YO, H Tanaka, YU, KT, HY, H Tsuji, MS, RN, KN, and AK have no competing interests to be reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}